CD8A and neoplasm: To determine the optimal route of vaccination for inducing efficacious overall and HPV-specific CD8+ T-cell immune responses, C57BL/6J non-tumor bearing (TB) mice were subcutaneously and intravenously vaccinated with HPV mRNA-LNPs.